All Stories

  1. Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?

    Article • Current Pharmaceutical Design, March 2020, Bentham Science Publishers

    Prof. Antonio Simone Laganà, Salvatore caruso, Grzegorz Jakiel

  2. Perceptions of attending medical staff by women accessing pregnancy termination in Poland: a qualitative study

    Article • The European Journal of Contraception & Reproductive Health Care, March 2019, Taylor & Francis

    Grzegorz Jakiel

  3. Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy – 2 case studies

    Article • Gynecological Endocrinology, January 2019, Taylor & Francis

    Grzegorz Jakiel

  4. Alpha-Tocopherol Serum Levels Are Increased in Caucasian Women with Uterine Fibroids: A Pilot Study

    Article • BioMed Research International, July 2018, Hindawi Publishing Corporation

    Grzegorz Jakiel